[144] BITMINE IMMERSION TECHNOLOGIES, INC. SEC Filing

Rhea-AI Filing Summary

BMNR has a planned insider sale of common stock under Rule 144. The notice covers 96,818 common shares to be sold through UBS Securities LLC on the NYSE, with an aggregate market value of $2,890,220.00. The issuer has 384,067,823 shares of this class outstanding, and the approximate sale date is 12/19/2025.

The seller acquired the 96,818 shares on 08/31/2022 via an LP distribution from the issuer. Over the past three months, related sales include 50,000 common shares by Jonathan Bates for $2,389,663.00, and three transactions by Progression Asset Management totaling 252,044 common shares for combined gross proceeds of over $8.5 million. The signing party represents that they are unaware of any undisclosed material adverse information about the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Securities LLC 11 Madison Avenue New York NY 10010	96818	2890220.00	384067823	12/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/31/2022	LP DISTRIBUTION	ISSUER			96818	08/31/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jonathan Bates 10845 Griffith Peak Drive Las Vegas NV 89135	common	09/22/2025	50000	2389663.00
Progression Asset Management 2018 Vine Street Los Angeles CA 90068	common	09/22/2025	100000	4779326.00
Progression Asset Management 2018 Vine Street Los Angeles CA 90068	Common	12/12/2025	152044	3773091.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BMNR Rule 144 notice disclose?

The notice discloses a planned sale of 96,818 BMNR common shares through UBS Securities LLC on the NYSE, with an aggregate market value of $2,890,220.00 and an approximate sale date of 12/19/2025.

How many BMNR shares are outstanding according to this filing?

The filing states that there are 384,067,823 BMNR common shares outstanding for the class of securities involved in the planned sale.

How and when were the 96,818 BMNR shares to be sold originally acquired?

The 96,818 BMNR common shares were acquired on 08/31/2022 through an LP distribution from the issuer, with the payment date also listed as 08/31/2022.

What BMNR share sales occurred in the past three months for this account?

In the last three months, Jonathan Bates sold 50,000 BMNR common shares for $2,389,663.00, and Progression Asset Management sold 100,000 common shares for $4,779,326.00 on 09/22/2025 and 152,044 common shares for $3,773,091.00 on 12/12/2025.

What representation does the seller make about BMNR in this Rule 144 filing?

The seller represents that they do not know any material adverse information about BMNR’s current or prospective operations that has not been publicly disclosed.

Which broker is handling the planned BMNR Rule 144 sale?

The planned sale of 96,818 BMNR common shares is to be executed through UBS Securities LLC, located at 11 Madison Avenue, New York, NY 10010.